Gufic Biosciences Limited
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufact… Read more
Gufic Biosciences Limited (GUFICBIO) - Total Assets
Latest total assets as of September 2025: ₹12.71 Billion INR
Based on the latest financial reports, Gufic Biosciences Limited (GUFICBIO) holds total assets worth ₹12.71 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gufic Biosciences Limited - Total Assets Trend (2006–2025)
This chart illustrates how Gufic Biosciences Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Gufic Biosciences Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Gufic Biosciences Limited's total assets of ₹12.71 Billion consist of 53.4% current assets and 46.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹290.22 Million | 2.5% |
| Accounts Receivable | ₹3.15 Billion | 26.9% |
| Inventory | ₹2.17 Billion | 18.6% |
| Property, Plant & Equipment | ₹5.21 Billion | 44.6% |
| Intangible Assets | ₹63.44 Million | 0.5% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Gufic Biosciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gufic Biosciences Limited's current assets represent 53.4% of total assets in 2025, a decrease from 55.1% in 2006.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, up from 1.6% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 22.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 44.6% of total assets.
Gufic Biosciences Limited Competitors by Total Assets
Key competitors of Gufic Biosciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Gufic Biosciences Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Gufic Biosciences Limited generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Gufic Biosciences Limited generates $5.96 in net profit.
Gufic Biosciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 1.63 | 1.34 |
| Quick Ratio | 1.06 | 1.11 | 0.82 |
| Cash Ratio | 0.19 | 0.05 | 0.00 |
| Working Capital | ₹2.58 Billion | ₹ 2.24 Billion | ₹ 689.17 Million |
Gufic Biosciences Limited - Advanced Valuation Insights
This section examines the relationship between Gufic Biosciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.92 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 7.0% |
| Total Assets | ₹11.69 Billion |
| Market Capitalization | $87.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Gufic Biosciences Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Gufic Biosciences Limited's assets grew by 7.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Gufic Biosciences Limited (2006–2025)
The table below shows the annual total assets of Gufic Biosciences Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹11.69 Billion | +7.03% |
| 2024-03-31 | ₹10.93 Billion | +26.87% |
| 2023-03-31 | ₹8.61 Billion | +65.16% |
| 2022-03-31 | ₹5.21 Billion | +32.99% |
| 2021-03-31 | ₹3.92 Billion | -3.79% |
| 2020-03-31 | ₹4.08 Billion | +45.78% |
| 2019-03-31 | ₹2.80 Billion | +18.41% |
| 2018-03-31 | ₹2.36 Billion | +32.28% |
| 2017-03-31 | ₹1.78 Billion | +17.26% |
| 2016-03-31 | ₹1.52 Billion | +19.57% |
| 2015-03-31 | ₹1.27 Billion | +14.52% |
| 2014-03-31 | ₹1.11 Billion | +24.08% |
| 2013-03-31 | ₹895.76 Million | +20.84% |
| 2012-03-31 | ₹741.28 Million | +22.33% |
| 2011-03-31 | ₹605.98 Million | +9.07% |
| 2010-03-31 | ₹555.57 Million | +17.05% |
| 2009-03-31 | ₹474.65 Million | -3.09% |
| 2008-03-31 | ₹489.81 Million | -8.65% |
| 2007-03-31 | ₹536.16 Million | -2.38% |
| 2006-03-31 | ₹549.21 Million | -- |